T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
XYZ
Block, Inc.
XYZ
|
+$2.23B |
| 2 |
Carvana
CVNA
|
+$1.65B |
| 3 |
Microsoft
MSFT
|
+$1.46B |
| 4 |
Affirm
AFRM
|
+$1.2B |
| 5 |
Walt Disney
DIS
|
+$1.18B |
Top Sells
| 1 |
Visa
V
|
+$2.51B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.93B |
| 4 |
Salesforce
CRM
|
+$1.88B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.52B |
Sector Composition
| 1 | Technology | 25.2% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.34% |
| 4 | Communication Services | 13.81% |
| 5 | Financials | 12.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Zentalis Pharmaceuticals
ZNTL
$118M
| $249M | 0.02% |
3,730,425
+470,857
| +14% | +$31.4M |
|
477
Banco Santander Chile
BSAC
$12.1B
| $246M | 0.02% |
12,464,221
+603,385
| +5% | +$11.9M |
|
478
PennyMac Financial
PFSI
$6.26B
| $244M | 0.02% |
3,998,944
-55,225
| -1% | -$3.38M |
|
479
Lennox International
LII
$20.4B
| $244M | 0.02% |
830,855
-237,717
| -22% | -$69.9M |
|
480
Infosys
INFY
$70.5B
| $244M | 0.02% |
10,977,347
-479,289
| -4% | -$10.7M |
|
481
Colgate-Palmolive
CL
$68.1B
| $244M | 0.02% |
3,229,075
-29,757
| -0.9% | -$2.25M |
|
482
Motorola Solutions
MSI
$79.6B
| $244M | 0.02% |
1,049,098
+107,862
| +11% | +$25.1M |
|
483
Rexford Industrial Realty
REXR
$10.2B
| $240M | 0.02% |
4,234,218
+130,691
| +3% | +$7.42M |
|
484
Denali Therapeutics
DNLI
$2.25B
| $240M | 0.02% |
4,757,965
-145,487
| -3% | -$7.34M |
|
485
Campbell Soup
CPB
$10.1B
| $240M | 0.02% |
5,728,571
+264,741
| +5% | +$11.1M |
|
|
EQC
486
DELISTED
Equity Commonwealth
EQC
| $239M | 0.02% |
9,199,824
+5,407,361
| +143% | +$140M |
|
|
PPBI
487
DELISTED
Pacific Premier Bancorp
PPBI
| $237M | 0.02% |
5,717,268
-94,034
| -2% | -$3.9M |
|
488
RTX Corp
RTX
$203B
| $235M | 0.02% |
2,738,049
+253,006
| +10% | +$21.7M |
|
489
Diamondback Energy
FANG
$39.5B
| $235M | 0.02% |
2,482,064
-42,021
| -2% | -$3.98M |
|
490
Darling Ingredients
DAR
$4.94B
| $235M | 0.02% |
3,265,873
+428,748
| +15% | +$30.8M |
|
|
JBGS
491
JBG SMITH
JBGS
$1.42B
| $235M | 0.02% |
7,923,346
-825,248
| -9% | -$24.4M |
|
492
Fate Therapeutics
FATE
$113M
| $235M | 0.02% |
3,956,495
+846,663
| +27% | +$50.2M |
|
493
PROG Holdings
PRG
$1.4B
| $234M | 0.02% |
5,579,174
-28,435
| -0.5% | -$1.19M |
|
494
Belden
BDC
$5.16B
| $234M | 0.02% |
4,021,728
-116,709
| -3% | -$6.8M |
|
495
Reynolds Consumer Products
REYN
$4.85B
| $234M | 0.02% |
8,557,514
+558,713
| +7% | +$15.3M |
|
496
Southwest Gas
SWX
$5.58B
| $233M | 0.02% |
3,483,498
+270,078
| +8% | +$18.1M |
|
497
Reliance Steel & Aluminium
RS
$15.4B
| $233M | 0.02% |
1,635,294
+17,251
| +1% | +$2.46M |
|
|
PXD
498
DELISTED
Pioneer Natural Resource Co.
PXD
| $232M | 0.02% |
1,395,103
-647,432
| -32% | -$108M |
|
499
SPX Corp
SPXC
$9.34B
| $231M | 0.02% |
4,325,393
+62,929
| +1% | +$3.36M |
|
500
Bristol-Myers Squibb
BMY
$96.1B
| $231M | 0.02% |
3,899,199
+325,660
| +9% | +$19.3M |
|